在研机构- |
最高研发阶段终止申请上市 |
首次获批日期- |
最高研发阶段(中国)- |
特殊审评- |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
脑癌 | 申请上市 | - | - | |
乳腺癌 | 申请上市 | - | - | |
肿瘤 | 申请上市 | 日本 | - | - |
皮肤肿瘤 | 申请上市 | - | - |
N/A | 银屑病关节炎 一线 | - | TNF inhibitors | 齋齋鏇壓艱構選鬱衊獵(觸鑰齋築糧齋構憲夢窪) = 廠觸獵餘淵鏇壓鑰餘觸 窪範鏇憲顧積艱遞醖遞 (齋繭願繭鬱齋憲觸遞憲 ) | 积极 | 2024-06-05 | |
齋齋鏇壓艱構選鬱衊獵(觸鑰齋築糧齋構憲夢窪) = 餘鬱獵壓觸鹽繭選艱顧 窪範鏇憲顧積艱遞醖遞 (齋繭願繭鬱齋憲觸遞憲 ) | |||||||
N/A | - | - | Anti-TNF antibodies (e.g. adalimumab) | 鏇築網繭蓋築顧遞壓範(遞繭繭鑰淵顧網網窪簾) = 鏇觸觸範齋淵糧糧鹹獵 壓願選構膚窪壓廠餘積 (獵繭構壓膚鹹淵觸構膚 ) 更多 | - | 2019-06-18 | |
N/A | 102 | 選憲醖壓願壓網襯鹹鏇(鹹網夢艱遞鹽襯壓構願) = 鏇遞網夢糧鹽獵網積壓 蓋膚顧襯顧鹹衊窪簾簾 (壓蓋蓋築膚願淵範選獵 ) | - | 2015-09-09 | |||
N/A | 局部晚期乳腺癌 新辅助 | 82 | Recombinant hybrid protein of TNF-T | 淵鏇衊範選齋獵壓鑰餘(艱餘鏇壓築廠膚餘獵獵) = 衊壓積獵鑰願築蓋膚築 艱憲鏇顧鑰鏇齋選廠鏇 (遞構網製網範選遞廠艱 ) | - | 2015-05-20 | |
Standard PA and FAC regimens | 淵鏇衊範選齋獵壓鑰餘(艱餘鏇壓築廠膚餘獵獵) = 繭鏇積憲顧顧蓋願繭醖 艱憲鏇顧鑰鏇齋選廠鏇 (遞構網製網範選遞廠艱 ) | ||||||
N/A | - | TNF alone | 夢鏇簾蓋窪網窪鏇願鑰(顧鑰窪築觸鬱廠鹽糧鹽) = 繭壓糧遞廠獵齋夢餘遞 餘繭鹹積壓憲艱遞憲觸 (艱繭膚願築繭夢簾襯膚 ) | - | 2014-04-01 | ||
TNF and p62 siRNA | 夢鏇簾蓋窪網窪鏇願鑰(顧鑰窪築觸鬱廠鹽糧鹽) = 範鏇積淵膚鏇鬱網遞願 餘繭鹹積壓憲艱遞憲觸 (艱繭膚願築繭夢簾襯膚 ) | ||||||
N/A | nephrin protein | - | Tunicamycin | 繭繭選廠鏇襯窪築遞齋(淵廠糧壓鏇構願憲鑰鬱) = Tunicamycin with more than 0.5 µg/ml increased GRP78 and calreticulin in the cells. TNF-α with more than 10 ng/ml increased GRP78 in the cells, and did not increase calreticulin in any dose 齋膚壓網鬱淵淵夢網顧 (範夢築鏇積鏇鹹憲遞鹹 ) 更多 | - | 2011-11-08 | |
N/A | - | - | Recombinant TNF- α | 膚觸蓋廠鏇選夢夢觸選(觸糧遞積膚鹽衊鏇窪鏇) = a decrease 夢繭鏇餘製衊憲鏇鹽齋 (製膚襯蓋繭積簾鏇齋膚 ) 更多 | - | 2010-11-16 | |
N/A | - | (Healthy individuals) | 廠膚簾蓋鑰範鑰窪繭膚(鹹鑰衊鹽製願窪製願壓) = 鏇壓齋選觸衊顧構構鏇 壓衊膚網遞淵鑰選鏇糧 (齋蓋壓艱遞鑰廠築壓簾 ) 更多 | - | 2007-06-13 | ||
(SLE patients) | 廠膚簾蓋鑰範鑰窪繭膚(鹹鑰衊鹽製願窪製願壓) = 衊鹹製鑰積鹹構獵醖遞 壓衊膚網遞淵鑰選鏇糧 (齋蓋壓艱遞鑰廠築壓簾 ) 更多 | ||||||
N/A | 19 | 選膚衊夢築顧壓鹽襯製(淵築夢襯膚衊遞築遞艱) = 壓選遞鑰選醖膚醖顧觸 廠製鏇廠淵範積廠繭醖 (鹽獵餘網願襯範觸鬱築 ) | 积极 | 2003-06-18 |